Mahmoud Abouraya

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity

J. Sacco, L. Trepanier, C. McCarty, 2012, Pharmacogenetics and genomics.

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine

J. Sacco, L. Trepanier, M. Pinkerton, 2010, Archives of Toxicology.

Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.

J. Sacco, L. Trepanier, B. Kahl, 2011, British journal of clinical pharmacology.

Dapsone‐Associated Methemoglobinemia in a Patient With Slow NAT2*5B Haplotype and Impaired Cytochrome b5 Reductase Activity

J. Sacco, L. Trepanier, C. Kitchens, 2012, Journal of clinical pharmacology.